Annick Meertens
Overview
Explore the profile of Annick Meertens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Coile L, Meertens A, Shen A, Waalboer-Spuij R, Vossaert K, Verhaeghe E, et al.
Sci Rep
. 2024 Sep;
14(1):21739.
PMID: 39289416
Basal cell carcinoma (BCC) is the most frequent malignant tumour worldwide and incidences are rising rapidly. BCC grow locally, but can invade surrounding tissues. Little is known concerning their impact...
2.
Meertens A, Van Coile L, Van Iseghem T, Brochez L, Verhaeghe N, Hoorens I
Pharmacoeconomics
. 2024 May;
42(7):751-765.
PMID: 38755518
Background: Skin cancer's rising incidence demands understanding of its economic impact. The current understanding is fragmented because of the various methodological approaches applied in skin cancer cost-of-illness studies. Objective: This...
3.
Van Coile L, Brochez L, Verhaeghe E, Boone B, Meertens A, Ongenae K, et al.
J Eur Acad Dermatol Venereol
. 2023 May;
37(9):1792-1798.
PMID: 37147863
Background: Skin cancer incidences are increasing. Treatment for basal cell carcinomas (BCCs) can be questioned in certain patients. Treatment options are various, but Mohs micrographic surgery (MMS) has the highest...
4.
de Vos I, Meertens A, Hogenhout R, Remmers S, Roobol M
Eur Urol
. 2023 Apr;
84(4):426-434.
PMID: 37029074
Background: Considering the long natural history of prostate cancer (PCa), long-term results of the European Randomised Study of Screening for PCa (ERSPC) are crucial. Objective: To provide an update on...